Cambridge, MA, United States of America

Bradley Lether Pentelute

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 121(Granted Patents)


Location History:

  • Cambridge, MA (US) (2015 - 2024)
  • Revere, MA (US) (2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
27 patents (USPTO):

Title: The Innovative Mind of Bradley Lether Pentelute: A Pioneer in Antisense Delivery

Introduction: Bradley Lether Pentelute, based in Cambridge, MA, is a distinguished inventor with a notable track record of 26 patents. His innovative work primarily focuses on the development of novel peptide-based strategies for the delivery of therapeutic oligonucleotides. Pentelute's research has made significant contributions to the fields of molecular biology and medicine, particularly in addressing muscle diseases and infections.

Latest Patents: Among Pentelute's latest patents are groundbreaking advancements in the realm of antisense delivery. One such patent, titled “Trimeric peptides for antisense delivery,” describes a range of oligonucleotides, trimeric peptides, and peptide-oligonucleotide conjugates. This innovation is aimed at treating muscle diseases by administering these peptides and oligonucleotides to affected individuals. Another significant patent is focused on “Cell-penetrating peptides for antisense delivery,” which outlines oligonucleotides, cell-penetrating peptides, and peptide-oligonucleotide conjugates designed to combat muscle diseases as well as viral and bacterial infections.

Career Highlights: During his career, Pentelute has collaborated with prestigious institutions such as the Massachusetts Institute of Technology (MIT) and the President and Fellows of Harvard College. His work at these renowned institutions has been pivotal in advancing the understanding of peptide-based drug delivery systems, enabling targeted therapies that can significantly improve patient outcomes.

Collaborations: Pentelute has closely worked with prominent researchers, including Mark David Simon and Andrea Adamo. Their collaborative efforts have contributed to the development of innovative solutions in the treatment of various medical conditions, enhancing the field's overall knowledge and technological capabilities.

Conclusion: Bradley Lether Pentelute is an exemplary inventor whose contributions to antisense delivery and molecular therapeutics are commendable. With a strong patent portfolio and collaborations with leading research institutions, his work continues to inspire advancements in medical science, promising improved therapies for challenging health conditions. Pentelute's innovative spirit exemplifies the impact of dedicated research in transforming theoretical concepts into tangible medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…